Insiders

10/12 BillionToOne Q3 Swings to Profit, Revenue Rises; Shares Fall After Hours MT
29/25/29 Top Midday Stories: Electronic Arts Going Private in $55 Billion Deal; Genmab to Acquire Merus for $8 Billion MT
29/25/29 Exchange-Traded Funds, Equity Futures Higher Pre-Bell Monday Ahead of Trump, Democrats Meeting MT
01/25/01 Genmab Announces Changes to Its Executive Committee CI
01/25/01 Genmab's Chief Legal Officer Steps Down; Successor Named MT
20/24/20 Aadi Bioscience, Inc. Appoints Baiteng Zhao to its Board of Directors CI
30/24/30 HOOKIPA Pharma Names Julie O'Neill Nonexecutive Chair MT
16/24/16 Genmab Names First Chief Technology, Chief Commercial Officers; COO to Exit MT
16/24/16 Genmab COO Anthony Mancini Departs; Firm Names New CTO, CCO MT
16/24/16 Genmab Operations Chief Anthony Mancini Departing MT
16/24/16 Genmab A/S Announces Executive Changes CI
14/24/14 Genmab A/S Announces Executive Changes CI
28/23/28 Danish Biotechnology Group Genmab Names New Chief Strategy Officer MT
28/23/28 Genmab A/S Announces Appointment of Martine van Vugt to Chief Strategy Officer and Promotes to Executive Vice President Effective March 29, 2023 CI
13/22/13 Avantor Names Jonathan Peacock Chairman MT
29/22/29 Genmab A/S Elects Elizabeth O’Farrell to the Board of Directors CI
01/22/01 Genmab Appoints New Chief Legal Officer, Chief People Officer MT
01/22/01 Genmab A/S Announces Appointments of Birgitte Stephensen to Chief Legal Officer and Chris Cozic to Chief People Officer CI
22/21/22 Genmab Announces Appointment of Tahamtan Ahmadi to Newly Created Position of Chief Medical Officer, Head of Experimental Medicines CI
27/20/27 Genmab A/S Appoints Pernille Erenbjerg as Deputy Chairman CI
26/20/26 Genmab A/S Announces the Election of Mr. Jonathan Peacock to its Board of Directors for a One-Year Period CI
10/20/10 Genmab A/S Announces Anthony Mancini Will Join the Company as Executive Vice President and Chief Operating Officer, Effective March 23, 2020 CI
22/20/22 Genmab' Chairman of the Board of Directors, Mats Pettersson to Step Down from the Board At Annual General Meeting on March 26, 2020 CI
31/19/31 Genmab A/S Announces Executive Changes CI
11/19/11 Genmab A/S Announces Management Changes CI
No results for this search